OPTIMIZATION OF IRON THERAPY IN HEMODIALYSIS-PATIENTS TREATED WITH RHUEPO

被引：8
|
作者：
STIVELMAN, JC
机构：
[1] Renal Division Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
来源：
SEMINARS IN DIALYSIS | 1994年 / 7卷 / 04期
关键词：
D O I：
10.1111/j.1525-139X.1994.tb00788.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：288 / 292
页数：5
相关论文
共 50 条
  • [31] INTRAVENOUS IRON IN ANEMIA TREATMENT OF HEMODIALYSIS-PATIENTS
    LOBOS, AV
    REMEDIO, F
    CALADO, J
    RAMOS, A
    CARVALHO, F
    RIBEIRO, F
    KIDNEY INTERNATIONAL, 1994, 45 (01) : 285 - 285
  • [32] THE UTILITY OF ZINC PROTOPORPHYRIN FOR PREDICTING THE NEED FOR INTRAVENOUS IRON THERAPY IN HEMODIALYSIS-PATIENTS
    FISHBANE, S
    LYNN, R
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) : 426 - 432
  • [33] ERYTHROPOIETIN TREATMENT IN HEMODIALYSIS-PATIENTS WITH IRON OVERLOAD
    ELRESHAID, K
    JOHNY, KV
    HAKIM, A
    KAMEL, H
    SEBETA, A
    HOURANI, H
    KANYIKE, FB
    ACTA HAEMATOLOGICA, 1994, 91 (03) : 130 - 135
  • [34] Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients
    Besarab, A
    Amin, N
    Ahsan, M
    Vogel, SE
    Zazuwa, G
    Frinak, S
    Zazra, JJ
    Anandan, JV
    Gupta, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2000, 11 (03): : 530 - 538
  • [35] ONCE WEEKLY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN HEMODIALYSIS-PATIENTS
    LAGO, M
    PEREZGARCIA, R
    DEVINUESA, MSG
    VILLAVERDE, M
    ANAYA, F
    VALDERRABANO, F
    KIDNEY INTERNATIONAL, 1994, 46 (02) : 579 - 579
  • [36] IRON DEXTRAN PHARMACOKINETICS IN IRON-DEFICIENT HEMODIALYSIS-PATIENTS
    VANWYCK, D
    HAKIM, R
    MAYERSOHN, M
    ROE, D
    WILTBANK, T
    WINGARD, R
    KIRLIN, L
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 482 - 482
  • [37] Role of iron therapy in optimization of erythropoietin in hemodialysis patients
    Gigarrán, S
    Barril, G
    NEFROLOGIA, 2001, 21 (05): : 510 - 511
  • [38] EFFECTS OF HUMAN ERYTHROPOIETIN THERAPY IN HEMODIALYSIS-PATIENTS
    LEE, SG
    SOHN, SH
    PARK, SB
    KIM, HC
    KIDNEY INTERNATIONAL, 1992, 41 (05) : 1458 - 1458
  • [39] EMPIRIC THERAPY OF BACTEREMIA WITH TEICOPLANIN IN HEMODIALYSIS-PATIENTS
    BRODERSEN, HP
    BECKERS, B
    STOLPMANN, RM
    KOHL, D
    HOLTKAMP, W
    LARBIG, D
    CLINICAL NEPHROLOGY, 1995, 43 (05) : 347 - 347
  • [40] HEMODYNAMIC AND VOLUME CHANGES BY RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN THE TREATMENT OF ANEMIC HEMODIALYSIS-PATIENTS
    HORI, K
    ONOYAMA, K
    ISEKI, K
    FUJIMI, S
    FUJISHIMA, M
    CLINICAL NEPHROLOGY, 1990, 33 (06) : 293 - 298
12345